![]() |
|
To print: Select File and then Print from your browser's menu Title: Rifabutin Rescue Therapy Effective After Helicobacter Eradication Failures |
| URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R Retrieve&db=PubMed&list_uids=12662375&dopt=Abstract |
|
Helicobacter 2003;8:2:90-94. "'Rescue' Therapy with Rifabutin after Multiple Helicobacter pylori Treatment Failures" 04/16/2003 02:36:23 PM By David Loshak Rescue therapy based on the anti-mycobacterial drug rifabutin offers an "encouraging" rescue therapy after other agents have failed to eradicate [Helicobacter pylori. A rifabutin-based combination is a promising strategy after such key antibiotics as amoxicillin, clarithromycin, metronidazole and tetracycline have not countered the organism, report gastroenterological researchers in Madrid, Barcelona and Baracaldo, Spain. They pointed out that although eradication therapy using a proton pump inhibitor, clarithromycin or amoxicillin was widely used, it did often fail. Rescue therapy combining omeprazole, bismuth, tetracycline and metronidazole (or ranitidine bismuth citrate with these same antibiotics) had been recommended but even this did not work in a fifth of cases. The researchers, therefore, used a prospective multi-centre study to evaluate the efficacy and tolerability of a rifabutin-based regimen in 14 patients who had experienced consecutive H. pylori eradication failures on those two regimens. The patients were aged 42 ± 11 years, six were men. Eight patients had peptic ulcer and six had dyspepsia. All completed the study protocol. This third eradication regimen consisted of twice-daily rifabutin 150 mg. amoxicillin 1.0 gram and omeprazole 20 mg. for 14 days. All drugs were administered together after breakfast and dinner. Adherence to therapy was determined from questioning patients and from the recovery of empty envelopes of medications. The researchers defined H. pylori eradication as a negative 13C-urea breath test eight weeks after completing the treatment. Per-protocol and intention-to-treat eradication was achieved in 11 cases. Five had adverse effects such as abdominal pain, nausea and vomiting and oral candidiasis but none stopped treatment as a result. http://www.docguide.com/news/content.nsf/WebOpenPaper_TopAbstracts"OpenAgent&newsid=8525697700573E1885256CF90036565E" 'Rescue' Therapy with Rifabutin after Multiple Helicobacter pylori Treatment Failures 2003-03-31 Helicobacter |
| http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R Retrieve&db=PubMed&list_uids=12662375&dopt=Abstract |
|
Copyright © 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. Go back This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 2009 P\S\L Consulting Group Inc. All rights reserved. |